A 1 month study of 2 modified Pfizer vaccines, one targeted specifically for new Omicron variants, and the other targeted at earlier coronavirus and current Omicron variants show increases in anitbodies much higher than what current vaccines do. For Omicron specifically at 13 to 19 times more than what current vaccines increase antibodies, and for earlier variants and Omicron at 9 to 11 times more.